TetraLogic Pharmaceuticals tetralogicpharma.com

TetraLogic Pharmaceuticals is focused on the discovery and development of drugs to treat cancer through technology which allows drugs to be developed that unblock the cell death or apoptosis pathway, resulting in the death of tumor cells. TetraLogic's lead Smac mimetic drug, birinapant (formerly TL32711), is entering Phase 2 clinical trials and is being developed for both solid tumors and hematological malignancies as a single agent and in combination with several standard-of-care cancer therapi...Show all

TetraLogic Pharmaceuticals is focused on the discovery and development of drugs to treat cancer through technology which allows drugs to be developed that unblock the cell death or apoptosis pathway, resulting in the death of tumor cells. TetraLogic'...Show all

See All Exits Recent Exits

Phone: 610-889-9900

Fax:

343 Phoenixville Pike

Malvern, 19355
Pennsylvania, United States

TetraLogic Pharmaceuticals - Investments & Acquisitions

Show Real Data
See all Recent Investments
Date Company Round Amount Co-investors
2014-04-07Shape PharmaceuticalsAcquired
See all 1 investments